Apalutamide (apa) for metastatic castration-sensitive prostate cancer (mcspc): Outcomes in high-volume (hv) and low-volume (lv) disease from the titan final analysis (fa) Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Chowdhury, S.; Bjartell, A.; Merseburger, A. S.; Chung, B. H.; Uemura, H.; Ye, D.; Ozguroglu, M.; De Santana, Gomes A. J. P.; Juarez, Soto A.; Given, R.; Mundle, S.; Bhaumik, A.; Brookman-May, S.; Lefresne, F.; McCarthy, S. A.; Chi, K. N.; Agarwal, N.

publication date

  • June 1, 2021


published in


start page

  • S1180

end page

  • S1181


  • 79